Advertisement
PHG vs STE
Which Stock Would AI Choose? Koninklijke Philips N.V. (PHG) vs. STERIS plc (STE) Stock Comparison
Key Takeaways
- Both PHG and STE operate in the healthcare sector, with PHG focused on health technology and diagnostics while STE specializes in infection prevention and sterilization solutions.
- Recent market activity shows PHG trading near $26 amid ongoing challenges in key markets like China, contrasted with STE near $214 following its fiscal year-end reporting.
- PHG exhibits greater exposure to imaging and connected care segments, whereas STE benefits from recurring demand in procedural support services.
- Relative performance reflects sector-wide pressures, with both stocks influenced by regulatory environments and global supply chain dynamics over recent weeks.
- Market sentiment for PHG has been tempered by demand variability, while STE maintains a more consistent operational profile in essential healthcare infrastructure.
Introduction
This comparison examines PHG and STE, two established healthcare equities, to highlight differences in business models, recent price behavior, and positioning within the broader market. Investors and traders seeking exposure to medical technology and services may find the analysis useful for evaluating relative strengths in a sector shaped by innovation, regulation, and demographic trends. The review draws on observable data from recent market activity to provide a balanced perspective on their trajectories.
PHG Overview and Recent Performance
Koninklijke Philips N.V. operates as a global health technology company with segments in diagnosis and treatment, connected care, and personal health. Its offerings include diagnostic imaging, image-guided therapy, and monitoring solutions. In recent weeks, PHG has traded in a range around $26, influenced by variable demand patterns particularly in international markets. Broader sentiment has reflected earnings considerations and external factors such as regional economic conditions, contributing to measured price movements amid sector volatility.
STE Overview and Recent Performance
STERIS plc provides infection prevention, sterilization, and procedural products and services primarily to healthcare and life sciences customers. The company focuses on capital equipment, consumables, and service contracts that support recurring revenue streams. Over recent market activity, STE has fluctuated near the $214 level following its latest fiscal reporting cycle. Performance has been shaped by steady procedural volumes and operational execution, with sentiment remaining steady despite broader healthcare sector headwinds.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available that trade thousands of different tickers. Only the most suitable bots for prevailing market conditions are featured in this section, based on metrics such as win rates often ranging from 60-85%, average trade durations spanning minutes to days, and profit factors typically between 1.5 and 3.0 across various strategies. These bots encompass diverse trading styles, timeframes, risk parameters, and ticker sets, enabling users to explore automated approaches tailored to equities like those in healthcare. Review the options on the Trending AI Robots page to identify potential fits for individual objectives.
Head-to-Head Comparison
PHG and STE differ markedly in their core operations: the former emphasizes diagnostic and therapeutic technologies with exposure to capital equipment cycles, while the latter centers on essential infection control and support services that generate more predictable demand. Growth drivers for PHG include advancements in imaging and digital health, tempered by international market variability; STE draws from expanding procedural needs and service contracts. Recent momentum has shown PHG more sensitive to external demand shifts, whereas STE has demonstrated relative resilience in its niche. Risk factors include regulatory scrutiny for both, with PHG additionally navigating supply and regional challenges, and STE facing capital expenditure and competition considerations. Sector exposure overlaps in healthcare but contrasts in cyclical versus defensive characteristics, influencing overall market sentiment.
Tickeron AI Verdict
Based on factors such as trend consistency, operational stability, and relative positioning in recent market activity, Tickeron’s AI models currently assign a modestly higher probabilistic preference to STE over PHG. This assessment reflects STE’s steadier demand profile and service-oriented model compared with PHG’s greater sensitivity to variable international conditions. The outlook remains subject to evolving catalysts and broader market dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHG is a StrongBuy and STE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PHG’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).
- PHG’s FA Score: 1 green, 4 red.
- STE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PHG’s TA Score shows that 4 TA indicator(s) are bullish while STE’s TA Score has 6 bullish TA indicator(s).
- PHG’s TA Score: 4 bullish, 6 bearish.
- STE’s TA Score: 6 bullish, 4 bearish.
Price Growth
PHG (@Medical/Nursing Services) experienced а +0.50% price change this week, while STE (@Medical/Nursing Services) price change was +6.69% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.50%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -17.67%.
Reported Earning Dates
PHG is expected to report earnings on Nov 03, 2026.
STE is expected to report earnings on Aug 10, 2026.
Industries' Descriptions
@Medical/Nursing Services (+2.50% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| PHG | STE | PHG / STE | |
| Capitalization | 25.6B | 22.3B | 115% |
| EBITDA | 3.01B | 1.59B | 189% |
| Gain YTD | 0.904 | -9.411 | -10% |
| P/E Ratio | 20.12 | 28.80 | 70% |
| Revenue | 17.7B | 5.94B | 298% |
| Total Cash | 1.79B | N/A | - |
| Total Debt | 7.47B | 2.09B | 358% |
PHG | STE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 87 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 2 Undervalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 79 | |
SMR RATING 1..100 | 71 | 67 | |
PRICE GROWTH RATING 1..100 | 57 | 49 | |
P/E GROWTH RATING 1..100 | 100 | 76 | |
SEASONALITY SCORE 1..100 | 50 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (2) in the Electronic Production Equipment industry is in the same range as STE (9) in the Medical Specialties industry. This means that PHG’s stock grew similarly to STE’s over the last 12 months.
STE's Profit vs Risk Rating (79) in the Medical Specialties industry is in the same range as PHG (100) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
STE's SMR Rating (67) in the Medical Specialties industry is in the same range as PHG (71) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
STE's Price Growth Rating (49) in the Medical Specialties industry is in the same range as PHG (57) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
STE's P/E Growth Rating (76) in the Medical Specialties industry is in the same range as PHG (100) in the Electronic Production Equipment industry. This means that STE’s stock grew similarly to PHG’s over the last 12 months.
| PHG | STE | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 87% | 4 days ago 53% |
| Stochastic ODDS (%) | 4 days ago 58% | 4 days ago 59% |
| Momentum ODDS (%) | 4 days ago 61% | 4 days ago 53% |
| MACD ODDS (%) | 4 days ago 60% | 4 days ago 61% |
| TrendWeek ODDS (%) | 4 days ago 61% | 4 days ago 52% |
| TrendMonth ODDS (%) | 4 days ago 59% | 4 days ago 47% |
| Advances ODDS (%) | 5 days ago 66% | 6 days ago 48% |
| Declines ODDS (%) | 12 days ago 62% | 4 days ago 57% |
| BollingerBands ODDS (%) | 4 days ago 70% | 4 days ago 69% |
| Aroon ODDS (%) | 4 days ago 61% | 4 days ago 49% |
Advertisement
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with GEHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then GEHC could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | -0.53% | ||
| GEHC - PHG | 51% Loosely correlated | -2.75% | ||
| ALC - PHG | 49% Loosely correlated | -0.96% | ||
| ENOV - PHG | 43% Loosely correlated | -0.51% | ||
| STE - PHG | 42% Loosely correlated | -1.22% | ||
| BAX - PHG | 40% Loosely correlated | -2.21% | ||
More | ||||